Alembic Pharmaceuticals Limited Cyclophosphamide Export Data — India (DGFT 2022–2026)

Name: Alembic Pharmaceuticals Limited Cyclophosphamide Export Records India — #3 Exporter, 30 Shipments, $850.4K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Cyclophosphamide

India Pharmaceutical Trade Intelligence

$19.5M259 Suppliers114 CountriesHS 30049041

ExportsIndia → UNITED STATES83.8%India → ETHIOPIA2.3%

ImportsUNITED STATES → India$592.7K CANADA → India$11.9K

#1 Supplier: CIPLA LIMITED #1 Buyer: CIPLA USA

Alembic Pharmaceuticals Limited — Cyclophosphamide Exporter #3 | $850.4K Trade Value | TransData Nexus | TransData Nexus

Alembic Pharmaceuticals Limited — Cyclophosphamide Exporter Profile

Indian Pharmaceutical Exporter · #3 for Cyclophosphamide · $850.4K export value · DGFT Verified

Alembic Pharmaceuticals Limited is the #3 Indian exporter of Cyclophosphamide with $850.4K in export value and 30 verified shipments. Alembic Pharmaceuticals Limited holds a 4.4% market share in Cyclophosphamide exports across 1 countries. The company exports 37 pharmaceutical products worth $127.6M across 16 therapeutic categories.

Alembic Pharmaceuticals Limited — Cyclophosphamide Export Profile: Buyers & Destinations

Alembic Pharmaceuticals Limited Cyclophosphamide export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Cyclophosphamide?

Country	Value	Shipments	Share
UNITED STATES	$11.1M	221	81.9%
ETHIOPIA	$445.0K	26	3.3%
PERU	$279.4K	27	2.1%
PHILIPPINES	$277.3K	58

Who Are the Top Buyers of Cyclophosphamide from India?

Buyer	Country	Value	Orders
EUGIA US LLC	UNITED STATES	$550.0K	11
CIPLA USA INC UPS SUPPLY CHAIN SOLU	UNITED STATES	$500.0K	10
J. KNIPPER & COMPANY	UNITED STATES	$467.5K	14
EUGIA US LLC,	UNITED STATES	$400.0K	8
AMBICA INTERNATIONAL CORPORATION	PHILIPPINES	$269.0K	55
COMMERCIAL BANK	ETHIOPIA	$250.0K	5
TO THE	UNITED ARAB EMIRATES	$209.4K	8
J KNIPPER COMPANY	UNITED STATES	$185.6K	4
HIRAD PHARMED UNIT	IRAN	$181.9K	11
AUROMEDICS PHARMA, LLC,.,	UNITED STATES	$100.0K	2

India's Cyclophosphamide is purchased by 518 buyers worldwide. The top buyer is EUGIA US LLC (UNITED STATES), followed by CIPLA USA INC UPS SUPPLY CHAIN SOLU and J. KNIPPER & COMPANY.

How Does Alembic Pharmaceuticals Limited Compare to Nearest Cyclophosphamide Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	EUGIA PHARMA SPECIALITIES LIMITED	$1.1M	22	1	$50.0K
3	ALEMBIC PHARMACEUTICALS LIMITED ★	$850.4K	30	1	$28.3K
1	CIPLA LIMITED	$550.0K	11	1	$50.0K
4	VENUS REMEDIES LIMITED	$492.4K	13	5	$37.9K

Alembic Pharmaceuticals Limited ranks #3 among 259 Indian Cyclophosphamide exporters. Average shipment value of $28.3K compared to the market average of $17.9K. The closest competitors by value are EUGIA PHARMA SPECIALITIES LIMITED and CIPLA LIMITED.

Which Indian Ports Ship Cyclophosphamide Exports?

Port	Shipments	% Share
SAHAR AIR	561	26.5%
SAHAR AIR CARGO ACC (INBOM4)	442	20.9%
DELHI AIR	246	11.6%
DELHI AIR CARGO ACC (INDEL4)	189	8.9%
Bombay Air	154	7.3%
Delhi Air	51	2.4%
Bombay Air Cargo	51	2.4%
HYDERABAD AIR	36	1.7%

Geopolitical & Trade Policy Impact on Alembic Pharmaceuticals Limited's Cyclophosphamide Exports

Alembic's export operations are intricately linked to global trade routes, making them susceptible to geopolitical tensions. The recent escalation of conflicts in the Middle East, particularly the Israel-Iran tensions, has led to heightened security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor. Major carriers have altered their routes, opting for the longer passage around the Cape of Good Hope, resulting in extended transit times by 10–20 days and increased freight rates by 40–50% on key India–Europe routes. (livemint.com) For Alembic, which exports to European markets, these disruptions could lead to delays and elevated shipping costs, impacting supply chain efficiency and profitability.

Conversely, the ongoing U.S.-China trade tensions have created opportunities for Indian pharmaceutical exporters. The United States' efforts to diversify its supply chain away from China have opened avenues for companies like Alembic to strengthen their presence in the U.S. market. The company's proactive approach is evident in its acquisition of Utility Therapeutics Ltd., facilitating entry into the U.S. branded drug segment. (pharma.economictimes.indiatimes.com) However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for Alembic's operations in Europe. Ensuring adherence to serialization and traceability requirements is essential to maintain market access and avoid regulatory penalties.

Alembic Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Alembic Pharmaceuticals has consistently demonstrated adherence to stringent regulatory standards set by agencies such as the USFDA, WHO, and EU GMP. The company's manufacturing facilities have received approvals from various international regulatory bodies, underscoring its commitment to quality and compliance. (en.wikipedia.org) Notably, Alembic's proactive approach to addressing regulatory challenges is evident in its successful resolution of the nitrosamine issue affecting products like Duloxetine. By stabilizing the product and obtaining necessary dossier approvals, the company has reinforced its dedication to product safety and regulatory compliance. (alembiclimited.com)

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Cyclophosphamide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Alembic Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 114+ countries, 518+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Cyclophosphamide

Cyclophosphamide

Alembic Pharmaceuticals Limited — Cyclophosphamide Exporter Profile

Alembic Pharmaceuticals Limited — Cyclophosphamide Export Profile: Buyers & Destinations

Where Does India Export Cyclophosphamide?

Who Are the Top Buyers of Cyclophosphamide from India?

What Is India's Total Cyclophosphamide Export Value and How Much Does Alembic Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Alembic Pharmaceuticals Limited's Cyclophosphamide Exports?

How Does Alembic Pharmaceuticals Limited Compare to Other Indian Cyclophosphamide Exporters?

Regulatory Requirements: Exporting Cyclophosphamide to Key Markets

United States — FDA

Mexico — COFEPRIS

How Does Alembic Pharmaceuticals Limited Compare to Nearest Cyclophosphamide Exporters?

Which Indian Ports Ship Cyclophosphamide Exports?

What Other Oncology Products Does Alembic Pharmaceuticals Limited Export?

Geopolitical & Trade Policy Impact on Alembic Pharmaceuticals Limited's Cyclophosphamide Exports

Alembic Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Alembic Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Cyclophosphamide Export Data from Alembic Pharmaceuticals Limited

Cyclophosphamide Stats

Company Overview

Top Products by Alembic Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source